May 31, 2017 11:06 am UTC| Business
PHILADELPHIA, May 31, 2017 -- Anexinet Corporation, a leading provider of digital, analytics and hybrid IT solutions, today announced its Mobile Customer Self-Service (MCSS) development platform. The new offering gives...
Bellicum Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 11:05 am UTC| Business
HOUSTON, May 31, 2017 -- Bellicum Pharmaceuticals, Inc.(Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced thatRick Fair,...
Bellicum Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 11:05 am UTC| Business
HOUSTON, May 31, 2017 -- Bellicum Pharmaceuticals, Inc.(Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced thatRick Fair,...
Bellicum Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 11:05 am UTC| Business
HOUSTON, May 31, 2017 -- Bellicum Pharmaceuticals, Inc.(Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced thatRick Fair,...
Bellicum Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 11:05 am UTC| Business
HOUSTON, May 31, 2017 -- Bellicum Pharmaceuticals, Inc.(Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced thatRick Fair,...
Bellicum Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 11:05 am UTC| Business
HOUSTON, May 31, 2017 -- Bellicum Pharmaceuticals, Inc.(Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced thatRick Fair,...
Bellicum Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 11:05 am UTC| Business
HOUSTON, May 31, 2017 -- Bellicum Pharmaceuticals, Inc.(Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced thatRick Fair,...